A multicenter pilot phase II study for the preliminary evaluation of feasibility, activity and safety of the administration of Bendamustine and Ofatumumab in combination in marginal zone B-cell lymphomas (MZL) [Studio multicentrico pilota di fase II per la valutazione preliminare della fattibilita' attivita' e tollerabilita' della somministrazione della combinazione ofatumumab e bendamustina in pazienti affetti da linfoma B marginale (MZL)]

Trial Profile

A multicenter pilot phase II study for the preliminary evaluation of feasibility, activity and safety of the administration of Bendamustine and Ofatumumab in combination in marginal zone B-cell lymphomas (MZL) [Studio multicentrico pilota di fase II per la valutazione preliminare della fattibilita' attivita' e tollerabilita' della somministrazione della combinazione ofatumumab e bendamustina in pazienti affetti da linfoma B marginale (MZL)]

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Jan 2017

At a glance

  • Drugs Bendamustine (Primary) ; Ofatumumab (Primary)
  • Indications MALT lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Jan 2017 Status changed from recruiting to completed.
    • 03 Aug 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top